Status:
COMPLETED
Validation of Digital Heart Rhythm Devices in the Detection of Atrial Fibrillation
Lead Sponsor:
Ziekenhuis Oost-Limburg
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The VALIDATION study aims to evaluate the performance of four state-of-the-art digital heart rhythm devices (Preventicus®, FibriCheck®, Apple Watch®, 6L Kardia Mobile®) for the detection of atrial fib...
Eligibility Criteria
Inclusion
- The patient is an ambulatory cardiology patient.
- The patient is at least 18 years old.
- The patient is sinus or in atrial fibrillation.
- The patient is able to perform the study procedures together with the study assistant.
Exclusion
- Patients with a pacemaker
- Inclusion in another clinical trial that may influence the results of this trial
- The patient is unable to comprehend the informed consent.
Key Trial Info
Start Date :
July 3 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 17 2023
Estimated Enrollment :
126 Patients enrolled
Trial Details
Trial ID
NCT06023290
Start Date
July 3 2023
End Date
November 17 2023
Last Update
December 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ziekenhuis Oost-Limburg
Genk, Limburg, Belgium, 3600